一、会议召开和出席情况 1、会议召开情况 | 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-054 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示： 1、本次股东大会不存在变更、否决提案的情况； 2、本次股东大会不涉及变更前次股东大会已通过的决议。 （1）会议召开时间、地点及召开方式 漱玉平民大药房连锁股份有限公司（以下简称"公司"）2025 年第三次临时股东大会 于 2025 年 6 月 25 日下午 2:45 在山东省济南市历城区山大北路 56 号公司会议室以现场表 决和网络投票相结合的方式召开。通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 6 月 25 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投 票系统进行投票的具体时间为 2025 年 6 月 25 日 9:15-15:00 ...

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-055 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于持股 5%以上股东、董事、高级管理人员权益变动比例 特别提示： 1、本次权益变动为持股 5%以上股东、董事、高级管理人员秦光霞女士实施之前披露的 减持股份计划导致的变动，不涉及要约收购。 2、本次权益变动后，持股 5%以上股东、董事、高级管理人员秦光霞女士的股份由变动 前的 73,440,000 股减少至 72,340,000 股，占公司总股本的比例从 18.25%减少至 17.98%。 3、本公告中计算相关比例、数量时，总股本均为剔除公司回购专用账户股份后的股份 数量。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 5 月 27 日披露了 《关于持股 5%以上股东、董事、高级管理人员减持股份预披露的公告》，持股 5%以上股东、 董事、高级管理人员秦光霞女士计划在该公告发布之日起 15 个交易日后的 3 个月内（即 2025 年 6 月 19 日至 2025 年 9 ...

Core Viewpoint - The credit rating of Shuyu Pming Pharmaceutical Chain Co., Ltd. remains stable at AA- due to its strong competitive position in the Shandong pharmaceutical retail industry, despite facing challenges from policy adjustments and market competition [3][5][6]. Company Overview - Shuyu Pming is a leading pharmaceutical retail company in Shandong, maintaining a strong competitive edge with a focus on expanding its presence in other provinces and enhancing online sales [3][4]. - The company has experienced a slowdown in revenue growth and profitability due to policy changes affecting the pharmaceutical retail sector, leading to a significant loss in 2024 [5][6][7]. Financial Performance - As of March 2025, the company's total assets are valued at 94.17 billion, with total liabilities at 53.33 billion and equity at 20.68 billion [3][4]. - The company's revenue for 2024 is projected at 23.79 billion, a decrease from 95.70 billion in 2023, indicating a challenging financial environment [3][4]. - The net profit for 2024 is expected to be -2.05 billion, reflecting a significant decline in profitability [4][6]. Industry Context - The pharmaceutical retail industry is entering an adjustment phase, with increased competition and regulatory changes leading to a decline in the number of drugstores nationwide [5][10]. - The industry is experiencing a shift from rapid expansion to a focus on operational efficiency and value enhancement, as major players adapt to changing market conditions [10][11]. Operational Challenges - The company faces challenges in cost control and operational efficiency, with a high debt-to-equity ratio and increased short-term repayment pressure [6][7]. - Compliance risks have emerged due to regulatory scrutiny, with instances of violations leading to penalties and operational disruptions [7][10]. Future Outlook - The credit rating agency maintains a stable outlook for the company, anticipating that it will continue to hold a leading position in the Shandong market despite the challenges [6][7]. - The company plans to focus on improving operational efficiency and enhancing the quality of its existing stores rather than pursuing aggressive expansion strategies [13][14].

漱玉平民大药房连锁股份有限公 司相关债券2025年跟踪评级报告 中鹏信评【2025】跟踪第【265】号 01 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情况。 本评级报告版权归本评级机构所有，未经授 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于近日收到公司控股股东、实 际控制人李文杰先生的通知，获悉其所持有公司的部分股份办理了补充质押业务，具体事 项如下： 一、控股股东股份质押基本情况 | | 是否为 控股股 东或第 | 本次补充 | 占其 所持 | 占公 司总 | 是否 | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | | | | | | 为补 | 质押 | 质押 | | 质押 | | 名称 | 一大股 | 质押数量 | 股份 | 股本 | 为限 | 充质 | 起始日 | 到期日 | 质权人 | 用途 | | | 东及其 | （股） | 比例 | 比例 | 售股 | 押 | | | | | | | 一致行 | | （%） | （%） | | | | | | | | | 动人 | | | | | | | | | | | 李文杰 | 是 | 10,000,000 | 7.0 ...

A股医药商业板块水下拉起，一心堂封板涨停，漱玉平民、健之佳、华人健康、第一医药、益丰药房等 跟涨。 ...

Group 1 - The company held its fourth meeting of the fourth Supervisory Board, which was convened by the chairperson Meng Peng, with all three supervisors present, complying with relevant laws and regulations [1] - The Supervisory Board approved the proposal to conclude certain fundraising projects and permanently supplement working capital with the remaining funds, which is seen as a reasonable decision to enhance the efficiency of fund usage and beneficial for the company's long-term development [1][2] - The proposal regarding the cancellation of unvested restricted stock due to the departure of two incentive targets and the failure to meet performance targets for the 2024 fiscal year was discussed, resulting in a total of 1.63205 million shares being rendered invalid [2][3] Group 2 - The voting results for the proposal to conclude fundraising projects showed unanimous support with 3 votes in favor, while the proposal regarding the cancellation of restricted stock could not be resolved due to insufficient non-related supervisors present to form a quorum [2][3] - The company plans to disclose further details regarding the cancellation of restricted stock on the official information platform [2][3]

证券代码：301017 证券简称：漱玉平民 公告编号：2025-051 债券代码：123172 债券简称：漱玉转债 漱玉平民大药房连锁股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"或"漱玉平民"）于 2025 年 6 月 9 日召开第四届董事会第七次会议和第四届监事会第四次会议，审议了《关于作废部分 已授予尚未归属的限制性股票的议案》，现将有关事项说明如下： 一、公司 2023 年限制性股票激励计划已履行的相关审批程序 议，审议通过了《关于公司<2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于 公司<2023 年限制性股票激励计划实施考核管理办法>的议案》等议案，公司独立董事对本 激励计划的相关事项发表了独立意见。 与职务在公司内部进行了公示。在公示期内，公司监事会未收到个人或组织提出的异议。 授予激励对象名单的核查意见及公示情况说明》。 司<2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于公司<2023 年限制性股票 激励计划实施考核管理办法>的议案》 《关于提 ...

Meeting Information - The company will hold its third extraordinary general meeting of shareholders on June 25, 2025, at 14:45, combining on-site voting and online voting [1][2] - The online voting will be available through the Shenzhen Stock Exchange trading system from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on the same day [1][2] Shareholder Rights - All shareholders registered by the close of trading on June 19, 2025, are entitled to attend the meeting and may appoint a proxy to attend and vote on their behalf [2][3] - The company will separately count and disclose the voting results of small and medium-sized investors [3] Agenda Items - The meeting will discuss a proposal to issue convertible bonds to unspecified objects and to permanently supplement working capital with the remaining funds from the issuance [2][3] Registration Details - Registration for the meeting can be done on-site, via mail, or email, with specific times and locations provided [3][4] - Natural person shareholders must present identification and proof of shareholding, while corporate shareholders must provide relevant documentation [4] Voting Procedures - Shareholders can vote online through the Shenzhen Stock Exchange trading system or the internet voting system, with detailed procedures outlined [6] - The voting code for the meeting is 351017, and shareholders must indicate their voting intentions clearly [6] Contact Information - The meeting will take place at the company's office in Jinan, Shandong Province, with contact details provided for inquiries [4][5]

证券代码：301017 证券简称：漱玉平民 公告编号：2025-050 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 6 月 9 日召开第四 届董事会第七次会议和第四届监事会第四次会议，审议通过了《关于向不特定对象发行可 转换公司债券部分募投项目结项并将节余募集资金永久补充流动资金的议案》，同意将"漱 玉（枣庄）现代化医药物流项目"结项并将节余募集资金 8,803.89 万元（含现金管理取得 的理财收益及活期利息收入，具体金额以资金转出当日银行结算余额为准）用于永久补充 流动资金。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》 债券代码：123172 债券简称：漱玉转债 漱玉平民大药房连锁股份有限公司 关于向不特定对象发行可转换公司债券部分募投项目结项 并将节余募集资金永久补充流动资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 《深圳 证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关规定，该 事项尚需提交公司股东大会审议。现将有关情况公告如下： （证监许可〔2022〕2 ...